Covid Led To A Record Year For Funding Infectious Disease Companies —Will That Continue? - News Summed Up

Covid Led To A Record Year For Funding Infectious Disease Companies —Will That Continue?


Venture capital funding for infectious disease companies reached an all-time high in 2020 at $2.9 billion according to an analysis conducted by Pitchbook for Forbes. “The profit opportunity compared to how risky it is to develop a new drug,” Rockman says, “that math is just much harder” for infectious disease companies. Funding for infectious disease companies from 2002-2021 PitchbookDespite past obstacles, Covid-19 completely changed how investors view infectious disease companies. Not all infectious disease companies have been underfunded. Hopefully, he says, the pandemic has turned the funding tide for the whole infrastructure of companies fighting infectious disease.


Source: Forbes June 10, 2021 13:52 UTC



Loading...
Loading...
  

Loading...